850759C

16:0-20:4 PE

1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine, chloroform

• 同義詞: 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine; PAPE; PE(16:0/20:4(5Z,8Z,11Z,14Z)); 110638
• 經驗公式（希爾表示法）: C₄₁H₇₄NO₈P
• CAS號碼: 70812-59-8
• 分子量：: 740.00
• 分類程式碼代碼: 51191904
• NACRES: NA.25

屬性

• 化驗: >99% (TLC)
• 形狀: powder
• 包裝: pkg of 1 × 2.5 mL (850759C-25mg)
• 製造商／商標名: Avanti Research^™ - A Croda Brand 850759C
• 濃度: 10 mg/mL (850759C-25mg)
• 脂質類型: cardiolipins; phospholipids
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• SMILES 字串: [H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)COC(CCCCCCCCCCCCCCC)=O

描述

應用

16:0-20:4 PE has been used to determine its effect on oxidative burst in neutrophil granulocytes. It has also been used to determine its detergent solubility with equimolar concentration of sphingomyelin/cholesterol (SM/CHOL).

包裝

5 mL Clear Glass Sealed Ampule (850759C-25mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全資訊

• 象形圖: GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• 防範說明: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• 危險分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• 標靶器官: Central nervous system, Liver,Kidney
• 儲存類別代碼: 6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: does not flash
• 閃點（°C）: does not flash